Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 4, 2022Orphanet Journal of Rare DiseasesOpen Access

Clinical features and treatment outcomes of pediatric Langerhans cell histiocytosis with macrophage activation syndrome-hemophagocytic lymphohistiocytosis

View Full Paper
Ask AI
Bookmark
Share

Authors

DWDong WangBeijing Tongren HospitalXCXihua ChenNational Health and Family Planning CommissionAWAng WeiMinistry of Education of the People's Republic of China

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2022) studied this question.

synapsesocial.com/papers/6aa0fea40799fb10dc5b8171https://doi.org/10.1186/s13023-022-02276-y
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Macrophage Activation and Hemophagocytic Syndrome in Langerhans Cell Histiocytosis: Report of 30 Cases2002 · 90 citations
  2. 2HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis2006 · 5,462 citations
  3. 3A New clinical score for disease activity in Langerhans cell histiocytosis2004 · 102 citations
  4. 4A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosis2018 · 37 citations
  5. 5Langerhans-Cell Histiocytosis2018 · 578 citations